A recent study from the University of Wisconsin, the University of Minnesota and the Scottish biomedical company Elasmogen suggests that antibodies created by sharks hold promise for preventing new coronavirus infections.
The small proteins, known as Variable New Antigen Receptors, or VNARs, appear to successfully neutralize coronavirus cells where larger human antibodies cannot.
Caroline Barelle, CEO of Elasmogen, joins to discuss this study.
Image Courtesy: Gerald Schombs / UNSPLASH
Did you enjoy this story? Your funding makes great, local journalism like this possible. Donate here
